Table 4. Bivariate and multivariate analysis of variables associated with ASM adherence (n = 357).

Variables	Category	Adherence to ASMs		COR (95% CI)	P-Value	AOR (95% CI)	P-Value
		Adherent (n)	Non-adherent (n)
Age (years)	18–24	53	41	1		1
	25–34	60	51	0.91 (0.52–1.58)	0.738	1.14(0.55–2.35)	0.729
	35–44	43	35	0.95 (0.52–1.74)	0.869	0.99(0.46–2.13)	0.969
	≥ 45	41	33	0.96 (0.52–1.78)	0.899	0.95 (0.42–2.18)	0.910
Sex	Female	96	77	1		1
	Male	101	83	0.98(0.64–1.48)	0.909	0.88(0.52–1.49)	0.637
Educational Status	No formal education	37	43	1		1
	Primary education (1–8)	45	50	1.05(0.58–1.90)	0.883	1.10 (0.53–2.30)	0.795
	Secondary education (9–12)	68	41	1.93(1.07–3.46)	0.028	2.21 (1.07–4.56)	0.032 *
	College and above	47	26	2.10(1.10–4.03)	0.025	2.61 (1.08–6.30)	0.032 *
Number of Anti-seizure medications	Monotherapy	138	89	1		1
	Polytherapy	59	71	0.54(0.35–0.83)	0.005	0.55 (0.32–0.96)	0.035 *
Comorbidity	No	171	137	1		1
	Yes	26	23	0.91(0.50–1.66)	0.748	0.78 (0.34–1.80)	0.557
Self-reported Availability of ASMs	Unavailable	35	36	1		1
	Available	162	124	1.34 (0.80–2.26)	0.266	2.01 (1.01–3.98)	0.046 *
Self-reported Affordability of ASMs	Unaffordable	82	85	1		1
	Affordable	115	75	1.59(1.04–2.42)	0.031	1.13 (0.64–2.01)	0.674
Financial Support	No	92	89	1		1
	Yes	38	34	1.08(0.63–1.87)	0.780	0.93 (0.52–1.68)	0.819

* Statistically Significant at P<0.05